Size
5 plates of 96 wells each
Catalog no#
CSB-E12153h-5x96
Price
2900 EUR
Tissue
cells
Disease
cancer
Notes
For research use only.
Specifications
Detection range: 0.78 U/mL-50 U/mL; Sensitivity: 0.195 U/mL
Test
ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Additional_information
Sample volume: 50-100ul; Detection wavelength: 450nm; Assay performance time: 1 to 4 hours.
Storage_and_shipping
Transported on ice packs/blue ice. Keep refrigerated at 2-8 degrees Celsius. Shelf life: 6 months.
Description
Quantitativesandwich ELISA kit for measuring Human receptor-binding cancer antigen expressed on SiSo cells,RCAS1 in samples from serum, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Additional description
Antigens are peptides or recombinant or native dependent on the production method.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.